Severe complications are rare and include anaphylaxis, mainly due to immunization against IgA in patients with IgA deficiency, haemolysis due to the presence of haemagglutinins in IVIg preparations [7], acute renal failure [8], stroke and myocardial infarction [9]. This evidence concerns the gene CD79A and anaphylaxis.